AMR surveillance in Nigeria is an important part of the country’s response to antimicrobial resistance. As bacteria and other microorganisms become less responsive to medicines healthcare professionals need reliable information to understand which treatments are still effective and where resistance is increasing.

Antimicrobial resistance can make common infections more difficult to treat. It can also lead to longer illnesses increased healthcare costs treatment complications and greater pressure on hospitals. Without good surveillance it is difficult to see these changes clearly or respond to them quickly.

For Nigeria strong surveillance means collecting accurate information from laboratories and healthcare facilities analysing resistance patterns and using the findings to improve treatment infection prevention antimicrobial stewardship and public health policies. It is not simply about collecting numbers. It is about turning health data into better decisions that can protect patients and communities.

What Is AMR Surveillance?

AMR surveillance is the continuous process of monitoring microorganisms and identifying how they respond to antimicrobial medicines. In healthcare settings laboratories can test samples from patients to determine which microorganisms are causing infections and whether those organisms are resistant or susceptible to specific medicines.

This information can then be collected and analysed to identify patterns.

For example if laboratories in several healthcare facilities begin reporting increased resistance to a particular antibiotic public health authorities can investigate the trend and healthcare professionals can review treatment practices.

Nigeria has national guidance for AMR laboratory surveillance that aims to support standardised testing reliable data collection quality assurance reporting and analysis. The guidance also highlights the importance of producing data that can be compared over time and across different locations.

Why AMR Surveillance in Nigeria Matters

Nigeria has a large and diverse healthcare system with major teaching hospitals general hospitals private facilities laboratories primary healthcare centres and community-based services.

Resistance patterns can differ between locations and healthcare settings. This makes local and national surveillance important.

AMR surveillance can help Nigeria:

• Detect changes in antimicrobial resistance patterns.
• Identify important resistant microorganisms.
• Support healthcare professionals in making treatment decisions.
• Strengthen antimicrobial stewardship programmes.
• Improve infection prevention and control.
• Guide public health policies.
• Identify areas where laboratory capacity needs improvement.
• Monitor the effectiveness of interventions.
• Provide evidence for national and international reporting.

The value of surveillance becomes clearer when the information is used. Data can help decision-makers understand where problems are developing and what actions may be needed.

How AMR Surveillance Works in Nigeria

Effective surveillance involves several connected steps. Each step needs to work properly for the final information to be useful.

Sample Collection

Surveillance often begins with a patient who has a suspected infection. A healthcare professional collects an appropriate clinical sample such as blood urine or another specimen depending on the suspected infection.

Correct collection and handling are essential because poor-quality samples can produce unreliable laboratory results.

Laboratory Identification

The laboratory examines the sample to identify the microorganism responsible for the infection. When appropriate antimicrobial susceptibility testing is performed to determine which medicines are likely to work.

Laboratory professionals need appropriate equipment supplies training and quality-control systems to produce dependable results.

Data Recording

Laboratory results are recorded along with relevant information about the infection and antimicrobial susceptibility. Consistent data collection makes it easier to compare findings between facilities and over time.

Data Analysis

The collected information can then be analysed to identify resistance patterns. Health professionals may examine which microorganisms are becoming more resistant which antimicrobial medicines are affected and whether resistance is changing over time.

Reporting and Action

The final and most important step is using the information. Surveillance findings can be shared with healthcare professionals public health authorities policymakers and other relevant stakeholders.

Nigeria’s surveillance guidance describes systems for reporting and sharing information so that AMR data can inform healthcare practice and policy.

The Role of Laboratories

Laboratories are at the heart of AMR surveillance in Nigeria. Without reliable laboratory testing it becomes much harder to understand the true level and pattern of antimicrobial resistance.

Laboratories need trained personnel appropriate equipment quality-assurance procedures regular supplies and reliable systems for recording and reporting results.

Reference laboratories also have an important role when unusual or unexpected resistance patterns are detected. Confirming unusual findings can help ensure that surveillance data remains accurate and can also help identify emerging resistance concerns.

Strengthening laboratory capacity particularly in areas where testing services are limited should therefore remain an important part of Nigeria’s AMR response.

Challenges Facing AMR Surveillance in Nigeria

Although Nigeria has developed surveillance guidelines and systems several challenges can affect the quality and coverage of available data.

One major challenge is limited laboratory capacity. Some facilities may not have the equipment or trained personnel needed to perform culture and antimicrobial susceptibility testing regularly.

Another issue is data reporting. Collecting information at a healthcare facility is only useful if the data can be accurately recorded shared and analysed.

Geographical coverage is also important. Data from a small number of facilities may not provide a complete picture of resistance across the entire country. Expanding surveillance to more healthcare settings can help produce a broader understanding of AMR.

Funding and maintenance are additional concerns. Laboratories require ongoing investment rather than one-time support. Equipment needs maintenance staff need training and supplies need to remain available.

These challenges show why AMR surveillance requires long-term planning and commitment.

AMR Surveillance and Antimicrobial Stewardship

Surveillance and antimicrobial stewardship work closely together.

Antimicrobial stewardship promotes the appropriate use of antimicrobial medicines. To make good decisions healthcare professionals need information about local resistance patterns.

For example if surveillance shows that a particular microorganism is frequently resistant to a commonly used medicine healthcare facilities can review their treatment guidelines and prescribing practices.

In this way surveillance provides evidence while stewardship helps turn that evidence into action.

NNAST supports antimicrobial stewardship and the wider AMR response by promoting evidence-based practices professional education healthcare collaboration and stronger systems for detecting resistant organisms. Its work connects policy research healthcare facilities laboratories and public health activities.

The One Health Approach to AMR Surveillance

AMR is not limited to human healthcare. Resistant microorganisms can also affect animals food systems agriculture and the environment.

This is why Nigeria’s AMR response uses a One Health approach. Different sectors need to share information and work together because resistance can move between people animals and the environment.

National AMR priorities include surveillance and detection alongside infection prevention and control public awareness access to diagnostics capacity building research and healthcare system strengthening.

A stronger One Health surveillance system can provide a broader picture of antimicrobial resistance and help authorities identify risks that may otherwise remain hidden.

How Better Surveillance Can Improve Healthcare

Reliable surveillance can have a direct impact on patient care.

When healthcare professionals have access to current resistance information they can make better-informed treatment decisions. Laboratories can provide evidence to support diagnosis and medicine selection while hospitals can use surveillance results to improve infection prevention and antimicrobial stewardship.

At the national level surveillance data can help policymakers identify areas that need additional investment or technical support.

It can also help measure whether interventions are working. If resistance patterns change after a new stewardship or infection-control programme is introduced surveillance can provide evidence about the impact.

The goal is therefore not simply to produce reports. The real goal is better healthcare and safer treatment.

NNAST’s Role in Strengthening AMR Surveillance in Nigeria

The Nigerian National Antimicrobial Stewardship TaskForce (NNAST) plays an important role in Nigeria’s wider AMR response.

NNAST works with healthcare professionals laboratories government institutions researchers and other stakeholders to support the implementation of national AMR priorities. Its role includes technical support capacity building antimicrobial stewardship research policy support and collaboration.

NNAST also identifies strengthening AMR surveillance and detection as one of the important features of Nigeria’s current national response. By helping connect evidence policy healthcare practice and public health needs NNAST can contribute to stronger and more practical surveillance systems.

The Way Forward

Nigeria can strengthen AMR surveillance by investing in laboratory infrastructure training healthcare and laboratory professionals improving data systems expanding surveillance coverage and encouraging timely reporting.

Standardised testing and quality assurance should remain priorities. Data should also be shared in a way that allows healthcare professionals and policymakers to use it effectively.

Most importantly surveillance should be connected to action. Information about resistance is valuable only when it helps improve treatment infection prevention antimicrobial stewardship and public health planning.

Conclusion

AMR surveillance in Nigeria is a vital tool for understanding and controlling antimicrobial resistance. It helps identify resistant microorganisms monitor changing patterns guide treatment decisions and support stronger healthcare policies.

Nigeria has established important surveillance guidelines and continues to strengthen its national AMR response. However continued investment in laboratories trained professionals reliable data systems and cooperation across the One Health sectors is essential.

With stronger surveillance and organisations such as NNAST supporting evidence-based action Nigeria can improve its ability to detect resistance early use antimicrobial medicines responsibly and protect effective treatments for future generations.